Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Mateus

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Revue De Pneumologie Clinique|January 24, 2007
[Cutaneous effects related to the use of tyrosine kinase inhibitors]Christine Mateus
Medecine Sciences : M/S|October 27, 2011
[Anti-CTLA-4 monoclonal antibody: a major step in the treatment of metastatic melanoma]Caroline Robert, Christine Mateus
La Revue Du Praticien|March 11, 2008
[Epithelial and melanic skin tumours]Christine Mateus, Caroline Robert
Bulletin Du Cancer|June 2, 2012
[Major therapeutic advances in the treatment of metastatic melanoma]Christine Mateus, Caroline Robert
The New England Journal of Medicine|November 4, 2011
Hemophilia A induced by ipilimumabJulie Delyon, Christine Mateus, Thierry Lambert
Bulletin Du Cancer|February 6, 2023
[End of life and cancer: Understanding the ethical issues of voluntary assisted dying]François Blot, Margot Fremaux, Christine Mateus
Bulletin Du Cancer|August 7, 2016
[Not Available]Christine Mateus, Cristina Libenciuc, Caroline Robert
Bulletin Du Cancer|May 6, 2014
[Detection of residual microscopic disease in melanoma: interest of the sentinel lymph node procedure?]Christine Mateus, Marina Thomas, Caroline Robert
Current Opinion in Oncology|December 31, 2010
RAF inhibition and induction of cutaneous squamous cell carcinomaCaroline Robert, Jean-Philippe Arnault, Christine Mateus
Cancer Immunology, Immunotherapy : CII|July 30, 2018
Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort studyTony Ibrahim, Christine Mateus, Maria Baz, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Revue De Pneumologie Clinique|January 24, 2007
[Cutaneous effects related to the use of tyrosine kinase inhibitors]Christine Mateus
Medecine Sciences : M/S|October 27, 2011
[Anti-CTLA-4 monoclonal antibody: a major step in the treatment of metastatic melanoma]Caroline Robert, Christine Mateus
La Revue Du Praticien|March 11, 2008
[Epithelial and melanic skin tumours]Christine Mateus, Caroline Robert
Bulletin Du Cancer|June 2, 2012
[Major therapeutic advances in the treatment of metastatic melanoma]Christine Mateus, Caroline Robert
The New England Journal of Medicine|November 4, 2011
Hemophilia A induced by ipilimumabJulie Delyon, Christine Mateus, Thierry Lambert
Bulletin Du Cancer|February 6, 2023
[End of life and cancer: Understanding the ethical issues of voluntary assisted dying]François Blot, Margot Fremaux, Christine Mateus
Bulletin Du Cancer|August 7, 2016
[Not Available]Christine Mateus, Cristina Libenciuc, Caroline Robert
Bulletin Du Cancer|May 6, 2014
[Detection of residual microscopic disease in melanoma: interest of the sentinel lymph node procedure?]Christine Mateus, Marina Thomas, Caroline Robert
Current Opinion in Oncology|December 31, 2010
RAF inhibition and induction of cutaneous squamous cell carcinomaCaroline Robert, Jean-Philippe Arnault, Christine Mateus
Cancer Immunology, Immunotherapy : CII|July 30, 2018
Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort studyTony Ibrahim, Christine Mateus, Maria Baz, et al.
Pageof 9